Valuation North China Pharmaceutical Company.Ltd

Stocks

End-of-day quote Shanghai S.E. Other stock markets 2026-07-03			5-day change	1st Jan Change
4.590 ^CNY	+1.77%		+9.29%	-17.00%

05-25	North China Pharma Gets China Nod for Kidney Anemia Drug	MT
04-24	North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	16,781	20,452	10,981	9,780	8,870	9,488
Change	-	21.87%	-46.31%	-10.94%	-9.3%	6.96%
Enterprise Value (EV) ¹	25,126	28,923	20,346	19,939	18,660	19,162
Change	-	15.11%	-29.65%	-2%	-6.41%	2.69%
P/E	172x	1,084x	-15.9x	1,900x	69.9x	51.7x
PBR	2.74x	3.36x	2.07x	1.84x	1.65x	1.72x
PEG	-	-13.3x	0x	-19x	0x	1.2x
Capitalization / Revenue	1.46x	1.97x	1.05x	0.97x	0.9x	1.03x
EV / Revenue	2.19x	2.79x	1.94x	1.97x	1.89x	2.07x
EV / EBITDA	20.8x	23.7x	15.2x	15.7x	12.9x	12.6x
EV / EBIT	42x	48.2x	32.1x	37.2x	28.3x	30.6x
EV / FCF	-30.9x	-32x	112x	128x	49.1x	35.2x
FCF Yield	-3.24%	-3.12%	0.89%	0.78%	2.03%	2.84%
Dividend per Share ²	0.03	0.06	-	0.01	0.03	0.035
Rate of return	0.29%	0.5%	-	0.18%	0.58%	0.63%
EPS ²	0.06	0.011	-0.402	0.003	0.074	0.107
Distribution rate	50%	545%	-	333%	40.5%	32.7%
Net sales ¹	11,493	10,385	10,500	10,120	9,870	9,242
EBITDA ¹	1,209	1,221	1,343	1,272	1,447	1,517
EBIT ¹	597.9	600.1	634.8	536.4	658.9	627.2
Net income ¹	97.32	18.73	-689.2	4.89	127	183.1
Net Debt ¹	8,345	8,472	9,366	10,159	9,790	9,674
Reference price ²	10.290	11.920	6.400	5.700	5.170	5.530
Nbr of stocks (in thousands)	1,630,805	1,715,730	1,715,730	1,715,730	1,715,730	1,715,730
Announcement Date	4/28/21	4/27/22	4/21/23	3/29/24	3/27/25	4/17/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NORTH CHINA PHARMACEUTICAL COMPANY.LTD	-	-	-	-	1.16B
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	369.36B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%